EUVIMEDEUVIMED entdecken
Crossref

Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway

Da-Lin Sun, Zi-Yi Guo, Wen-Yuan Liu, Lin Zhang, Zi-Yuan Zhang, Ya-Ling Hu, Su-Fen Li, Ming-Yu Zhang, Guang Zhang, Jin-Jing Wang, Jing-Ai Fang

Chinese Journal of Integrative Medicine · 2025-05 · 31 (5) · 422-433

DOI: 10.1007/s11655-024-3568-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 23.07.2024. Verfasst von Da-Lin Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First College for Clinical Medicine, Shanxi Medical University, Taiyuan, 030001, China. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Saponins, Triterpenes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the effects of astragaloside IV (AS-IV) on podocyte injury of diabetic nephropathy (DN) and reveal its potential mechanism. METHODS: In in vitro experiment, podocytes were divided into 4 groups, normal, high glucose (HG), inositol-requiring enzyme 1 (IRE-1) α activator (HG+thapsigargin 1 µmol/L), and IRE-1α inhibitor (HG+STF-083010, 20 µmol/L) groups. Additionally, podocytes were divided into 4 groups, including normal, HG, AS-IV (HG+AS-IV 20 µmol/L), and IRE-1α inhibitor (HG+STF-083010, 20 µmol/L) groups, respectively. After 24 h treatment, the morphology of podocytes and endoplasmic reticulum (ER) was observed by electron microscopy. The expressions of glucose-regulated protein 78 (GRP78) and IRE-1α were detected by cellular immunofluorescence. In in vivo experiment, DN rat model was established via a consecutive 3-day intraperitoneal streptozotocin (STZ) injections. A total of 40 rats were assigned into the normal, DN, AS-IV [AS-IV 40 mg/(kg·d)], and IRE-1α inhibitor [STF-083010, 10 mg/(kg·d)] groups (n=10), respectively. The general condition, 24-h urine volume, random blood glucose, urinary protein excretion rate (UAER), urea nitrogen (BUN), and serum creatinine (SCr) levels of rats were measured after 8 weeks of intervention. Pathological changes in the renal tissue were observed by hematoxylin and eosin (HE) staining. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were used to detect the expressions of GRP78, IRE-1α, nuclear factor kappa Bp65 (NF-κBp65), interleukin (IL)-1β, NLR family pyrin domain containing 3 (NLRP3), caspase-1, gasdermin D-N (GSDMD-N), and nephrin at the mRNA and protein levels in vivo and in vitro, respectively. RESULTS: Cytoplasmic vacuolation and ER swelling were observed in the HG and IRE-1α activator groups. Podocyte morphology and ER expansion were improved in AS-IV and IRE-1α inhibitor groups compared with HG group. Cellular immunofluorescence showed that compared with the normal group, the fluorescence intensity of GRP78 and IRE-1α in the HG and IRE-1α activator groups were significantly increased whereas decreased in AS-IV and IRE-1α inhibitor groups (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesDiabetic NephropathiesSaponinsTriterpenesSignal TransductionNF-kappa BProtein Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinEndoribonucleasesAnimalsMaleRats, Sprague-DawleyEndoplasmic Reticulum Chaperone BiPRatsDiabetes Mellitus, ExperimentalEndoplasmic ReticulumMultienzyme Complexes

Stichwörter der Autor:innen

astragaloside IVdiabetic nephropathyinositol-requiring enzyme 1α/nuclear factor kappa Bp65/NLR family pyrin domain…podocyte

Substanzen

astragaloside ASaponinsTriterpenesNF-kappa BProtein Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinEndoribonucleasesErn1 protein, ratEndoplasmic Reticulum Chaperone BiPGRP78 protein, rat

Autor:innen und Institutionen

  • The First College for Clinical Medicine, Shanxi Medical University, Taiyuan, 030001, China.
  • Department of Nephrology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
  • Department of Nephrology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China. jingaifang2017003@126.com.

Zitieren

APA

Sun, D. L., Guo, Z. Y., Liu, W. Y., Zhang, L., Zhang, Z. Y., Hu, Y. L., Li, S. F., Zhang, M. Y., Zhang, G., Wang, J. J., & Fang, J. A. (2025). Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway. Chinese Journal of Integrative Medicine, 31(5), 422-433. https://doi.org/10.1007/s11655-024-3568-0

Vancouver

Sun DL, Guo ZY, Liu WY, Zhang L, Zhang ZY, Hu YL, et al. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway. Chinese Journal of Integrative Medicine. 2025;31(5):422-433. doi:10.1007/s11655-024-3568-0

BibTeX
@article{Sun2025,
  author = {Sun, Da-Lin and Guo, Zi-Yi and Liu, Wen-Yuan and Zhang, Lin and Zhang, Zi-Yuan and Hu, Ya-Ling and Li, Su-Fen and Zhang, Ming-Yu and Zhang, Guang and Wang, Jin-Jing and Fang, Jing-Ai},
  title = {Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway},
  journal = {Chinese Journal of Integrative Medicine},
  year = {2025},
  volume = {31},
  number = {5},
  pages = {422--433},
  doi = {10.1007/s11655-024-3568-0}
}
Kostenlos starten →